Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

OBJECTIVE: Parkinson’s disease (PD) is a neurological disorder, and ergot dopamine agonists (DAs) are no longer usually preferred in the treatment due to the increased risk of valvular heart disease. Some recent studies have shown that commonly used non-ergot DA also increases the risk of heart fail...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Anatol J Cardiol
Autors principals: Pamukcu, Hilal Erken, Uludağ, Demet Menekşe Gerede, Tak, Bahar Tekin, Sorgun, Mine Hayriye, Efe, Tolga Han, Acıbuca, Aynur, Akbostancı, Cenk, Turhan, Sibel
Format: Artigo
Idioma:Inglês
Publicat: Kare Publishing 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6249529/
https://ncbi.nlm.nih.gov/pubmed/30297579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2018.65983
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars